|
|
J Clin Pathol. 1995 June; 48(6): 501–508. | PMCID: PMC502677 |
Routine and specialised techniques in the diagnosis of haematological neoplasms. B J Bain Department of Haematology, St Mary's Hospital Medical School, London. Abstract The relative importance of traditional techniques used in the diagnosis of haematological neoplasms has altered during the past decade. Cytology and histology retain their central role but the importance of cytochemistry has declined, except in the diagnosis of AML. Immunophenotyping is of major importance in the diagnosis of ALL, some categories of AML and the LPDs. Cytogenetic and molecular genetic analysis are important in the diagnosis of CML and are becoming increasingly important in the diagnosis of chronic LPDs and other haematological neoplasms. Diagnostic haematology laboratories which are not specialist leukaemia centres should have ready access to all of these techniques to ensure optimal patient management. However, not all techniques need to be performed in every laboratory. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Lithotripsy. Health and Public Policy Committee, American College of Physicians. Ann Intern Med. 1985 Oct;103(4):626–629. [PubMed]
- Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol. 1989 Jun;42(6):567–584. [PMC free article] [PubMed]
- Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol. 1991 Jul;78(3):325–329. [PubMed]
- Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, Pui CH, Fairclough D, Berard CW. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986 Dec;4(12):1732–1739. [PubMed]
- Hann IM, Eden OB, Barnes J, Pinkerton CR. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG). Br J Haematol. 1990 Nov;76(3):359–364. [PubMed]
- Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1994 Jul 15;84(2):570–573. [PubMed]
- Bain B, Catovsky D. Current concerns in haematology. 2: Classification of acute leukaemia. J Clin Pathol. 1990 Nov;43(11):882–887. [PMC free article] [PubMed]
- Scott CS, Stark AN, Limbert HJ, Master PS, Head C, Roberts BE. Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 cases. Br J Haematol. 1988 Jun;69(2):247–252. [PubMed]
- Invernizzi R, Iannone AM, Bernuzzi S, D'Alessio A, Fiamenghi C, Ippoliti G, Scagliosi S, Ascari E. Acute promyelocytic leukemia: morphological and clinical features. Haematologica. 1993 MayâJun;78(3):156–161. [PubMed]
- Yam LT, Yam CF, Li CY. Eosinophilia in systemic mastocytosis. Am J Clin Pathol. 1980 Jan;73(1):48–54. [PubMed]
- Lilleyman JS, Britton JA, Anderson LM, Richards SM, Bailey CC, Chessells JM. Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia. J Clin Pathol. 1994 Aug;47(8):689–692. [PMC free article] [PubMed]
- Hoyle CF, Gray RG, Wheatley K, Swirsky D, de Bastos M, Sherrington P, Rees JK, Hayhoe FG. Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemia. Br J Haematol. 1991 Nov;79(3):398–407. [PubMed]
- Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol. 1993 Apr;99(4):504–512. [PubMed]
- Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vietti TJ, Look AT, Mahoney D, Ragab A, Pullen DJ, et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood. 1990 Jul 1;76(1):117–122. [PubMed]
- Lilleyman JS, Hinchliffe RF. Pre-B and 'common' lymphoblastic leukaemia of childhood compared. Br J Haematol. 1989 Feb;71(2):227–231. [PubMed]
- Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD, et al. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994 Jul 1;84(1):244–255. [PubMed]
- Secker-Walker LM. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1990 Oct 1;49(1):1–13. [PubMed]
- Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, Mirro J, Jr, Ochs JS, Look AT, Williams DL, et al. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet. 1991 Jan 12;337(8733):61–66. [PubMed]
- Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993 May 1;81(9):2237–2251. [PubMed]
- Barrett AJ. Bone marrow transplantation for acute lymphoblastic leukaemia. Baillieres Clin Haematol. 1994 Jun;7(2):377–401. [PubMed]
- Roberts WM, Rivera GK, Raimondi SC, Santana VM, Sandlund JT, Crist WM, Pui CH. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Lancet. 1994 Feb 5;343(8893):331–332. [PubMed]
- Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood. 1994 May 15;83(10):2780–2786. [PubMed]
- Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A, Frankel L, Harris M, Wagner H, Haggard M, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol. 1992 Apr;10(4):606–613. [PubMed]
- Seymour JF, Estey EH. The prognostic significance of auer rods in myelodysplasia. Br J Haematol. 1993 Sep;85(1):67–76. [PubMed]
- Spiers AS, Bain BJ, Turner JE. The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases. Scand J Haematol. 1977 Jan;18(1):25–38. [PubMed]
- Cervantes F, Robertson JE, Rozman C, Baccarani M, Tura S, Gómez GA, Braun TJ, Clarkson BD, Pereira A. Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group. Br J Haematol. 1994 Jun;87(2):293–300. [PubMed]
- Shepherd PC, Ganesan TS, Galton DA. Haematological classification of the chronic myeloid leukaemias. Baillieres Clin Haematol. 1987 Dec;1(4):887–906. [PubMed]
- Kantarjian HM, Kurzrock R, Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol Oncol Clin North Am. 1990 Apr;4(2):389–404. [PubMed]
- Lilleyman JS, Potter AM, Watmore AE, Cooke P, Sokol RJ, Wood JK. Myeloid karyotype and the malignant phase of chronic granulocytic leukaemia. Br J Haematol. 1978 Jul;39(3):317–323. [PubMed]
- Kloke O, Niederle N, Qiu JY, Wandl U, Moritz T, Nagel-Hiemke M, Hawig I, Opalka B, Seeber S, Becher R. Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia. Br J Haematol. 1993 Mar;83(3):399–403. [PubMed]
- Stoll DB, Peterson P, Exten R, Laszlo J, Pisciotta AV, Ellis JT, White P, Vaidya K, Bozdech M, Murphy S. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome. Am J Hematol. 1988 Feb;27(2):77–83. [PubMed]
- Demory JL, Dupriez B, Fenaux P, Laï JL, Beuscart R, Jouet JP, Deminatti M, Bauters F. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood. 1988 Sep;72(3):855–859. [PubMed]
- Bain BJ, Catovsky D. The leukaemic phase of non-Hodgkin's lymphoma. J Clin Pathol. 1995 Mar;48(3):189–193. [PMC free article] [PubMed]
- Matutes E, Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk Lymphoma. 1994;13 (Suppl 1):11–14. [PubMed]
|